My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Indicators

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

Thermo Fisher Scientific (NY:TMO)

587.48 +14.74 (+2.57%)

Official Closing Price Updated: 7:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

30 31 Next >

3 Nanotechnology Stocks That Could Soar as the Technology Advances ↗

March 14, 2024

A small world with big potential, nanotechnology stocks could soar in the coming years as demand for nanoscale applications grows.

Via InvestorPlace

Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs ↗

March 13, 2024

Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as demand for these treatments escalates.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

March 06, 2024

Via Benzinga

Thermo Fisher Stock Lights Up The Board, Soars 40% In 5 Months ↗

March 06, 2024

Thermo Fisher stock has risen more than 40% since October. Additionally, it's closed higher nine of the past 11 trading sessions.

Via Investor's Business Daily

Samsara, Thermo Fisher Scientific And More: CNBC's 'Final Trades' ↗

March 01, 2024

On CNBC’s "Halftime Report Final Trades," Karen Firestone of Aureus Asset Management said Thermo Fisher Scientific Inc. (NYSE: TMO) is coming back

Via Benzinga

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $15,000 Today ↗

February 06, 2024

Via Benzinga

Thermo Fisher Scientific: Q4 Earnings Insights ↗

January 31, 2024

Via Benzinga

Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink

March 01, 2024

From Thermo Fisher Scientific Inc.

Via Business Wire

Thermo Fisher Scientific to Present at TD Cowen 44th Annual Health Care Conference on March 6, 2024

February 28, 2024

From Thermo Fisher Scientific Inc.

Via Business Wire

Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 5 Years ↗

February 27, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 26, 2024

Via Benzinga

A Preview Of Thermo Fisher Scientific's Earnings ↗

January 30, 2024

Via Benzinga

Market Whales and Their Recent Bets on TMO Options ↗

January 26, 2024

Via Benzinga

Thermo Fisher Scientific Increases Quarterly Dividend

February 21, 2024

From Thermo Fisher Scientific Inc.

Via Business Wire

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness ↗

February 15, 2024

Although the healthcare innovation space has struggled recently, these contrarian biotech stocks now offer compelling discounts.

Via InvestorPlace

Ray Dalio's Bridgewater Makes Waves: Q4 Unveils Strategic Shifts With New Investments, Sector Expansion In Tech ↗

February 15, 2024

Bridgewater Associates, founded by Ray Dalio, made notable changes to its portfolio in Q4 2023. New bets, exits, increased stakes offer insights into its investment strategy.

Via Benzinga

Buy the Dip: 3 Oversold Stocks Poised for Big Gains ↗

February 15, 2024

Discover how these oversold stocks to buy point towards potential fast gains while their fundamentals support potentially further growth.

Via InvestorPlace

TransDigm, West Pharmaceutical, Thermo Fisher Scientific And A Tech Company On CNBC's 'Final Trades' ↗

February 08, 2024

On CNBC’s "Halftime Report Final Trades," Steve Weiss of Short Hills Capital Partners named TransDigm Group Incorporated (NYSE: TDG), which is scheduled to release

Via Benzinga

RBC Capital Maintains Outperform Rating for Thermo Fisher Scientific: Here's What You Need To Know ↗

February 01, 2024

Via Benzinga

Biotech And Medtech Portfolio Notes On A Fed Day ↗

January 31, 2024

The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23%

Via Talk Markets

Topics Economy

Buy Alert: 3 Stocks Sitting in the Sweet Spot ↗

January 31, 2024

They say timing is everything, so investors will want to take advantage of buying these stocks now instead of waiting.

Via InvestorPlace

Nasdaq, S&P 500 Slip Ahead Of Fed Meeting, Regional Banks Sink After NYCB Disappoints: What's Driving Markets Wednesday? ↗

January 31, 2024

Nasdaq down 1.4%, S&P 500 down 0.9%, Dow up: Volatile day on Wall Street as tech stocks react to disappointing earnings ahead of Fed meeting.

Via Benzinga

Topics Economy Stocks

Thermo Fisher Scientific (TMO) Q4 2023 Earnings Call Transcript ↗

January 31, 2024

TMO earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Medical Equipment Maker Thermo Fisher Scientific Clocks 7% Decline In Q4 Organic Sales, Issues Subdued Annual Outlook ↗

January 31, 2024

"Thermo Fisher Scientific surpasses Q4 revenue expectations at $10.89B, down 5% YoY. Analytical Instruments Segment rises 8.5%. Financial highlights and 2024 revenue guidance.

Via Benzinga

Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser ↗

January 31, 2024

The record run of the market faces risk as the big tech earnings season got off to a negative start, casting cloud on profit outlook.

Via Benzinga

Topics Economy

Earnings Scheduled For January 31, 2024 ↗

January 31, 2024

Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.

Via Benzinga

Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2023 Results

January 31, 2024

From Thermo Fisher Scientific Inc.

Via Business Wire

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

January 30, 2024

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END

Via FinancialNewsMedia

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

January 30, 2024

From FN Media Group LLC

Via GlobeNewswire

Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism? ↗

January 29, 2024

An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending.

Via Benzinga

Topics Artificial Intelligence

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition